ERK inhibition attenuates 5-HT-induced contractions in fetal and adult ovine carotid arteries

Archives of Physiology and Biochemistry

Volumn 111, Issue 1, 2003, Pages 36-44

  Pearce, William J ^a   Williams, J M ^a   Chang, M M ^a   Gerthoffer, W T ^b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Caldesmon; Carotid arteries; ERK; Fetal development; MAP kinases; Maturation; Ontogeny; Ovine; PD098059; Serotonin; UO126; Vascular smooth muscle

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALDESMON; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SEROTONIN; SEROTONIN 2A RECEPTOR;

AGE; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FETUS; FORCE; LAMB; NONHUMAN; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; SHEEP; SMOOTH MUSCLE CONTRACTION; WESTERN BLOTTING;

AGE FACTORS; ANIMALS; BUTADIENES; CALMODULIN-BINDING PROTEINS; CAROTID ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETUS; FLAVONOIDS; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE CONTRACTION; MYOSIN-LIGHT-CHAIN KINASE; MYOSINS; NITRILES; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; SEROTONIN; SHEEP;

ANIMALIA; LAMB; OVIS; OVIS ARIES;

EID: 0037306131     PISSN: 13813455     EISSN: None     Source Type: Journal    
DOI: 10.1076/apab.111.1.36.15143     Document Type: Article

References (44)

1. Adam LP, Gapinski CJ, Hathaway DR (1992): Phosphorylation sequences in h-caldesmon from phorbol ester-stimulated canine aortas. FEBS Lett 302: 223-226.
2. Adam LP, Hathaway DR (1993): Identification of mitogen-activated protein kinase phosphorylation sequences in mammalian h-Caldesmon. FEBS Lett 322: 56-60.
3. Akopov SE, Zhang L, Pearce WJ (1997): Physiological variations in ovine cerebrovascular calcium sensitivity. Am J Physiol 272: H2271-H2281.
4. Akopov SE, Zhang L, Pearce WJ (1998): Regulation of Ca2+ sensitization by PKC and rho proteins in ovine cerebral arteries: effects of artery size and age. Am J Physiol 275: H930-H939.
5. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR (1995): PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494.
6. Angeles DM, Williams J, Zhang L, Pearce WJ (2000): Acute hypoxia modulates 5-HT receptor density and agonist affinity in fetal and adult ovine carotid arteries. Am J Physiol Heart Circ Physiol 279: H502-H510.
7. Arner A, Pfitzer G (1999): Regulation of cross-bridge cycling by Ca2+ in smooth muscle. Rev Physiol Biochem Pharmacol 134: 63-146.
8. Belcheva MM, Coscia CJ (2002): Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase. Neurosignals 11: 34-44.
9. Cobb MH, Hepler JE, Cheng M, Robbins D (1994): The mitogen-activated protein kinases, ERK1 and ERK2. Semin Cancer Biol 5: 261-268.
10. D'Angelo G, Adam LP (2002): Inhibition of ERK attenuates force development by lowering myosin light chain phosphorylation. Am J Physiol Heart Circ Physiol 282: H602-H610.
11. D'Angelo G, Graceffa P, Wang CA, Wrangle J, Adam LP (1999): Mammal-specific, ERK-dependent, caldesmon phosphorylation in smooth muscle. Quantitation using novel anti-phosphopeptide antibodies. J Biol Chem 274: 30115-30121.
12. Davies SP, Reddy H, Caivano M, Cohen P (2000): Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105.
13. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR (1995): A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92: 7686-7689.
14. Earley JJ, Su X, Moreland RS (1998): Caldesmon inhibits active crossbridges in unstimulated vascular smooth muscle: an antisense oligodeoxynucleotide approach. Circ Res 83: 661-667.
15. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM (1998): Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632.
16. Force T, Bonventre JV (1998): Growth factors and mitogen-activated protein kinases. Hypertension 31: 152-161.
17. Gerthoffer WT, Gunst SJ (2001): Invited review: focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle. J Appl Physiol 91: 963-972.
18. Gorenne I, Su X, Moreland RS (1998): Inhibition of p42 and p44 MAP kinase does not alter smooth muscle contraction in swine carotid artery. Am J Physiol 275: H131-H138.
19. Kim I, Je HD, Gallant C, Zhan Q, Riper DV, Badwey JA, Singer HA, Morgan KG (2000): Ca2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta. J Physiol 52t(Pt 2): 367-374.
20. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA (1997): Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137: 481-492.
21. Krymsky MA, Kudryashov DS, Shirinsky VP, Lukas TJ, Watterson DM, Vorotnikov AV (2001): Phosphorylation of kinase-related protein (telokin) in tonic and phasic smooth muscles. J Muscle Res Cell Motil 22: 425-437.
22. Lagaud GJ, Lam E, Lui A, van Breemen C, Laher I (1999): Non-specific inhibition of myogenic tone by PD98059, a MEK1 inhibitor, in rat middle cerebral arteries. Biochem Biophys Res Commun 257: 523-527.
23. Lagaud GJ, Lam E, Lui A, van Breemen C, Laher I (1999): Non-specific inhibition of myogenic tone by PD98059, a MEK1 inhibitor, in rat middle cerebral arteries. Biochem Biophys Res Commun 257: 523-527.
24. Marandi S, De Keyser N, Stilmant C, Saliez A, Sokal EM, Guiot Y, Buts JP (2002): Ontogeny of MAP kinases in rat small intestine: premature stimulation by insulin of BBM hydrolases is regulated by ERKs but not by p-38 MAP kinase. Pediatr Res 52: 180-188.
25. Morgan KG, Gangopadhyay SS (2001): Invited review: cross-bridge regulation by thin filament-associated proteins. J Appl Physiol 91: 953-962.
26. Morrison DL, Sanghera JS, Stewart J, Sutherland C, Walsh MP, Pelech SL (1996): Phosphorylation and activation of smooth muscle myosin light chain kinase by MAP kinase and cyclin-dependent kinase-1. Biochem Cell Biol 74: 549-557.
27. Nixon GF, Iizuka K, Haystead CM, Haystead TA, Somlyo AP, Somlyo AV (1995): Phosphorylation of caldesmon by mitogen-activated protein kinase with no effect on Ca2+ sensitivity in rabbit smooth muscle. J Physiol 487(Pt 2): 283-289.
28. Owens GK (1995) Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517.
29. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH (2001): Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183.
30. Pereira DB, Carvalho AP, Duarte CB (2002): Non-specific effects of the MEK inhibitors PD098,059 and U0126 on glutamate release from hippocampal synaptosomes. Neuropharmacology 42: 9-19.
31. Pritchard K, Moody CJ (1986): Caldesmon: a calmodulin-binding actin-regulatory protein. Cell Calcium 7: 309-327.
32. Ratz PH (2001): Regulation of ERK phosphorylation in differentiated arterial muscle of rabbits. Am J Physiol Heart Circ Physiol 281: H114-H123.
33. Somlyo AP, Somlyo AV (1994): Signal transduction and regulation in smooth muscle. Nature 372: 231-236.
34. Stull JT, Tansey MG, Word RA, Kubota Y, Kamm KE (1991): Myosin light chain kinase phosphorylation: regulation of the Ca2+ sensitivity of contractile elements. Adv Exp Med Biol 304: 129-138.
35. Takahashi E, Berk BC (1998): MAP kinases and vascular smooth muscle function. Acta Physiol Scand 164: 611-621.
36. Teng GQ, Williams J, Zhang L, Purdy R, Pearce WJ (1998): Effects of maturation, artery size, and chronic hypoxia on 5-HT receptor type in ovine cranial arteries. Am J Physiol 275: R742-R753.
37. Ward DT, Alder AC, Ohanian J, Ohanian V (2002): Noradrenaline-induced paxillin phosphorylation, ERK activation and MEK-regulated contraction in intact rat mesenteric arteries. J Vasc Res 39: 1-11.
38. Watts SW (1996): Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD098059. J Pharmacol Exp Ther 279: 1541-1550.
39. Watts SW, Yang P, Banes AK, Baez M (2001): Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors. J Cardiovasc Pharmacol 38: 539-551.
40. Winder SJ, Walsh MP (1993): Calponin: thin filament-linked regulation of smooth muscle contraction. Cell Signal 5: 677-686.
41. Xiao D, Zhang L (2002): ERK MAP kinases regulate smooth muscle contraction in ovine uterine artery: effect of pregnancy. Am J Physiol Heart Circ Physiol 282: H292-H300.
42. Yamboliev IA, Hedges JC, Mutnick JL, Adam LP, Gerthoffer WT (2000): Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway. Am J Physiol Heart Circ Physiol 278: H1899-H1907.
43. Yamboliev IA, Hruby A, Gerthoffer WT (1998): Endothelin-1 activates MAP kinases and c-Jun in pulmonary artery smooth muscle. Pulm Pharmacol Ther 11: 205-208.
44. Zhang Y, Moreland S, Moreland RS (1994): Regulation of vascular smooth muscle contraction: myosin light chain phosphorylation dependent and independent pathways. Can J Physiol Pharmacol 72(11): 1386-1391.